A Novel Ex Vivo Drug Assay for Assessing the Transmission-Blocking Activity of Compounds on Field-Isolated Plasmodium falciparum Gametocytes

The discovery and development of transmission-blocking therapies challenge malaria elimination and necessitate standard and reproducible bioassays to measure the blocking properties of antimalarial drugs and candidate compounds. Most of the current bioassays evaluating the transmission-blocking acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouologuem, Dinkorma T., Dembele, Laurent, Dara, Antoine, Kone, Aminatou K., Diallo, Nouhoum, Sangare, Cheick P. O., Ballo, Fatoumata I., Dao, François, Goita, Siaka, Haidara, Aboubecrin S., Traore, Aliou, Niangaly, Amadou B., Dama, Souleymane, Sissoko, Sekou, Sogore, Fanta, Dara, Jacob N., Barre, Yacouba N., Daou, Amadou, Cisse, Fatoumata, Diakite, Ousmaila, Doumbia, Diagassan, Koumare, Sekou, Fofana, Bakary, Tandina, Fatalmoudou, Sylla, Daman, Sacko, Adama, Coulibaly, Mamadou, Tekete, Mamadou M., Ouattara, Amed, Djimde, Abdoulaye A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764978/
https://www.ncbi.nlm.nih.gov/pubmed/36321830
http://dx.doi.org/10.1128/aac.01001-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764978/
https://www.ncbi.nlm.nih.gov/pubmed/36321830
http://dx.doi.org/10.1128/aac.01001-22

Ejemplares similares